Insider Title Company Date Price Return Shares Value
Newton Charles W. Chief Financial Officer Lyell Immunopharma, Inc. (LYEL) 2025-03-17 $0.56 0.0% 200,000 $111,620
Return Profit / (loss) Cost
Total 0.0% $0 $111,620